Acquired immunodeficiency syndrome (AIDS) was first recognized in 1981 as a distinct
clinical entity, 1 and soon after the infectious nature of the disease became apparent, human …

Present evidence suggests that the acquired immune deficiency syndrome (AIDS) emerged
in Central Africa as a new disease in recent decades. This disease has recently approached …

Two synthetic peptides containing amino acid sequences analogous to the envelope
glycoprotein of human T‐lymphotropic virus (HTLV) type III (HTLV‐III) and lymphadenopathy …

Immunoassays for human immunodeficiency virus antigen (HIV Ag) and for antibody to HIV
core and envelope (CIA-RA) were done on serial specimens from 40 haemophiliacs who …

Sequential serum samples from 13 homosexual men who seroconverted for antibodies to
human immunodeficiency virus (HIV) were tested for HIV antigen. In one of these men, who …

Sixteen isolates of simian retrovirus closely related to human immunodeficiency virus (HIV)
were obtained from healthy African green monkeys (AGM)(Cercopithecus aethiops). The first …

AIDS is a disorder characterized by a slow progressive impairment of immune function and
by infection of human immunodeficiency viruses (HIV-1, HIV-2) 1–4. Our knowledge of how …

This study initiates an effort to develop a safe vaccine against the acquired
immunodeficiency syndrome (AIDS) that is caused by infection with a retrovirus designated …

Two human monoclonal antibodies (MAbs)(2F5 and 4E10) against the human
immunodeficiency virus type 1 (HIV-1) envelope g41 cluster II membrane proximal external …

A newly identified protein from HTLV-III/LAV, the virus implicated as the etiologic agent of the
acquired immune deficiency syndrome, was studied. This protein, which has a molecular …